Tracking OPRX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
OP
OptimizeRx Corporation (OPRX) short interest & options flow
NASDAQOptimizeRx faces one of its sharpest analyst repricing cycles in months, with three separate target cuts landing on May 13 — the same day Q1 results were digested. The Street moved quickly after the print. Stifel maintained its Buy but pulled its target from $17 to $14. B. Riley Securities also held Buy, trimming from $11 to $10. Stephens & Co. stayed at Equal-Weight and cut from…
$8.95-4.28% 1d-8.86% 1w+8.09% 1mClose: 11 Nov 2026
- Market cap
- $169M
- Next earnings
- 3 Mar 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 12 Nov 2026
OPRX news and analysis
RSSNo long-form analysis yet for OPRX. Pulse alerts and the live data picture are available on ORTEX.
Open OPRX on ORTEX →Want the live picture for OPRX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OPRX — free to start on ORTEX.
Sign up for free →Open OPRX on ORTEX